These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19238933)

  • 1. [Pneumology. Should we fear inhaled anticholinergic bronchodilators?].
    Rochat T; Janssens JP
    Rev Med Suisse; 2009 Jan; 5(186):135-7. PubMed ID: 19238933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of risk of neurovascular and cardiovascular side effects between tiotropium and other anticholinergic agents.
    Alzayer R; Hughes J; Parsons R; Lee YP
    Qual Prim Care; 2010; 18(3):189-99. PubMed ID: 20659403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.
    Hilleman DE; Malesker MA; Morrow LE; Schuller D
    Int J Chron Obstruct Pulmon Dis; 2009; 4():253-63. PubMed ID: 19657399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
    Somand H; Remington TL
    Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK
    Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of inhaled anticholinergic agents in obstructive airway disease.
    Restrepo RD
    Respir Care; 2007 Jul; 52(7):833-51. PubMed ID: 17594728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
    Singh S; Loke YK; Enright P; Furberg CD
    Thorax; 2013 Jan; 68(1):114-6. PubMed ID: 22764216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and tolerability of bronchodilators in chronic obstructive pulmonary disease].
    Sanjuás C
    Arch Bronconeumol; 2009; 45 Suppl 5():21-6. PubMed ID: 20116758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
    Singh S; Loke YK; Enright P; Furberg CD
    Postgrad Med J; 2014 Apr; 90(1062):205-7. PubMed ID: 24643260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Are there cardiovascular adverse effects of inhaled anticholinergics?].
    Nagy LB
    Orv Hetil; 2015 Aug; 156(31):1246-52. PubMed ID: 26211748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease.
    Tashkin DP
    Expert Opin Drug Saf; 2015; 14(11):1759-72. PubMed ID: 26401729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic agents in asthma and COPD.
    Gross NJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):36-9. PubMed ID: 16488410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA; Schumock GT; Bartle B; Pickard AS
    Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
    JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.
    Salpeter SR
    Drugs; 2009 Oct; 69(15):2025-33. PubMed ID: 19791824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled anticholinergic drugs and risk of acute urinary retention.
    Afonso AS; Verhamme KM; Stricker BH; Sturkenboom MC; Brusselle GG
    BJU Int; 2011 Apr; 107(8):1265-72. PubMed ID: 20880196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapies of COPD].
    Noseda A
    Rev Med Brux; 2003 Sep; 24(4):A354-7. PubMed ID: 14606301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiovascular risk of tiotropium: is it real?
    Cazzola M; Calzetta L; Matera MG
    Expert Opin Drug Saf; 2010 Sep; 9(5):783-92. PubMed ID: 20565229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.